HomeZVRA • NASDAQ
Zevra Therapeutics Inc
add
$8.66
0.58%
After Hours:(0.12%)+0.010
$8.67
Closed: May 21, 4:30:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 20.40M | 495.65% |
Operating expense | 24.42M | 2.87% |
Net income | -3.10M | 81.36% |
Net profit margin | -15.19 | 96.87% |
Earnings per share | -0.06 | 85.00% |
EBITDA | -3.71M | 80.38% |
Effective tax rate | -61.66% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 62.63M | 18.81% |
Total assets | 172.71M | 14.16% |
Total liabilities | 131.69M | 28.52% |
Total equity | 41.02M | — |
Shares outstanding | 54.68M | — |
Price to book | 11.48 | — |
Return on assets | -7.64% | — |
Return on capital | -13.22% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.10M | 81.36% |
Cash from operations | -8.22M | 49.14% |
Cash from investing | 10.54M | -28.74% |
Cash from financing | 1.61M | 32.05% |
Net change in cash | 3.56M | 1,877.50% |
Free cash flow | -9.51M | -43.04% |
Previous close
$8.61
Day range
$8.41 - $8.84
Year range
$4.20 - $9.76
Market cap
473.53M USD
Avg Volume
567.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2006
Website
Employees
59
